Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	Abacavir 300mg twice daily	Abacavir	2件: D00891, D07057 💬	-	-	1件: 265 💬
2	Acthar gel 40 units twice weekly	-	-	-	-	1件: 84 💬
3	Acthar gel 80 units twice weekly.	-	-	-	-	1件: 84 💬
4	All subjects will receive maraviroc 300mg orally twice a day for 6 weeks	Maraviroc	1件: D06670 💬	1件: CCR5 💬	9件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor	1件: 84 💬
5	Azli 75 mg two times a day (bid)/ three times a day (tid)	-	-	-	-	1件: 299 💬
6	Azli 75 mg two times a day (bid)/three times a day (tid)	-	-	-	-	1件: 299 💬
7	Budesonide 0.5mg orodispersible tablet twice daily	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
8	Budesonide 1mg orodispersible tablet twice daily	Budesonide	1件: D00246 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
9	Chinese herbal concoction twice a day for 6 months	-	-	-	-	1件: 60 💬
10	Colistimethate 75 mg inhaled two times daily	Colistimethate	1件: D02049 💬	-	-	1件: 299 💬
11	Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator	Acetate	2件: D00088, D00165 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
12	Fampridine-sr b.i.d. (twice daily)	Dalfampridine	1件: D04127 💬	4件: KCNA4, KCNC3, KCND2, KCND3 💬	4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia	1件: 13 💬
13	Fluticasone propionate, 800 mcg twice daily (post 4fed failure)	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
14	Fluticasone propionate, 880 mcg twice daily (after 6fed failure)	Fluticasone	2件: D01708, D07981 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 98 💬
15	Gentamicin infusions twice a week for six months	Gentamicin	2件: D01063, D08013 💬	-	-	1件: 113 💬
16	High dose bibf 1120 twice daily	-	-	-	-	1件: 85 💬
17	Intermediate dose bibf 1120 twice daily	-	-	-	-	1件: 85 💬
18	Jnj-54781532 75 mg twice daily	-	-	-	-	1件: 97 💬
19	Low dose bibf 1120 twice daily	-	-	-	-	1件: 85 💬
20	Mesalamine twice-daily	Mesalazine	1件: D00377 💬	-	-	1件: 97 💬
21	Multi-glycoside of tripterygium wilfordii hook. f. (twh)	Tripterygium wilfordii whole	-	-	-	1件: 66 💬
22	Mycophenolate mofetil orally 1000 mg twice a day (bid)	Mycophenolate mofetil	4件: D00752, D05094, D05095, D05096 💬	2件: IMPDH1, IMPDH2 💬	3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism	1件: 222 💬
23	Other: dummy tripterygium wilfordii hook f (twhf)	Tripterygium wilfordii whole	-	-	-	1件: 46 💬
24	Procedure: order of two elements of surgical procedure	-	-	-	-	1件: 51 💬
25	Pxt3003 dose 2 (equivalent to twice dose 1)	-	-	-	-	1件: 10 💬
26	Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82	Ammonia	1件: D02916 💬	-	-	1件: 86 💬
27	Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml)	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 271 💬
28	Tobi™ podhaler™ 112 mg inhaled twice daily	-	-	-	-	1件: 299 💬
29	Tofacitinib 5 mg twice daily	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 84 💬
30	Treatment of mtx and twhf	-	-	-	-	1件: 46 💬
31	Treatment of twhf	-	-	-	-	1件: 46 💬
32	Tripterygium wilfordii (tw)	Tripterygium wilfordii whole	-	-	-	2件: 66, 222 💬
33	Tripterygium wilfordii hook f (twhf)	Tripterygium wilfordii whole	-	-	-	1件: 46 💬
34	Tw	-	-	-	-	1件: 222 💬
35	Twhf	-	-	-	-	1件: 46 💬
36	Twice-daily dosage with 0.5% cyclosporine-a eyedrops	Cyclosporine	1件: D00184 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	1件: 90 💬

先頭へ